NOTABLE LABS, LTD. Patents: Applications Rejected

NOTABLE LABS, LTD. Patent Applications Rejected

22 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

2022-03-22: Application 17701255; Invention TREATMENT METHODS USING ADENOVIRUS; Applicant Vascular Biogenics Ltd.; Status Abandoned -- Failure to Respond to an Office Action.
2021-10-11: Application 17602963; Invention METHODS OF ANTI-TUMOR THERAPY; Applicant VASCULAR BIOGENICS LTD.; Status Abandoned -- Failure to Respond to an Office Action.
2021-09-13: Application 17438840; Invention METHODS OF ANTI-TUMOR THERAPY; Applicant VASCULAR BIOGENICS LTD.; Status Abandoned -- Failure to Respond to an Office Action.
2020-09-14: Application 16980659; Invention BISPECIFIC ANTIBODIES TO MOSPD2 AND T CELL- OR NK CELL-SPECIFIC MOLECULES; Applicant Vascular Biogenics Ltd.; Status Abandoned -- Failure to Respond to an Office Action.

Filed	Application	Invention	Applicant	Status	Published as	Inventor name	Inventor country	Examiner
2022-03-22	17701255	TREATMENT METHODS USING ADENOVIRUS	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20220331383A1	Eyal BREITBART Andrea LEUBITZ Erez FEIGE Richard PENSON	Israel Israel Israel United States	CHEN, SHIN LIN
2021-10-11	17602963	METHODS OF ANTI-TUMOR THERAPY	VASCULAR BIOGENICS LTD.	Abandoned -- Failure to Respond to an Office Action	US20220185891A1	Tamar RACHMILEWITZ MINEI Itzhak MENDEL Niva YACOV Eyal BREITBART	Israel Israel Israel Israel	EBBINGHAUS, BRIANA NOEL
2021-09-13	17438840	METHODS OF ANTI-TUMOR THERAPY	VASCULAR BIOGENICS LTD.	Abandoned -- Failure to Respond to an Office Action	US20220154212A1	Tamar RACHMILEWITZ MINEI Shifra FAIN-SHMUELI	Israel Israel	BATES, KEENAN ALEXANDER
2020-09-14	16980659	BISPECIFIC ANTIBODIES TO MOSPD2 AND T CELL- OR NK CELL-SPECIFIC MOLECULES	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20200407434A1	Itzhak MENDEL Yaniv SALEM Eyal BREITBART	Israel Israel Israel	LU, CHENG
2020-08-27	17005005	METHODS AND COMPOSITIONS FOR TUMOR RADIOSENSITIZATION	VASCULAR BIOGENICS, LTD. MEMORIAL SLOAN KETTERING CANCER CENTER	Abandoned -- Failure to Respond to an Office Action	US20210069330A1	Richard N. KOLESNICK Branka STANCEVIC Michel SADELAIN Zvi FUKS Nira VARDA-BLOOM Dror HARATS	United States United States United States United States Israel Israel	GODDARD, LAURA B
2020-04-15	16756216	DIAGNOSTIC METHODS FOR ANTI-ANGIOGENIC AGENT THERAPY	VASCULAR BIOGENICS LTD.	Abandoned -- Failure to Respond to an Office Action	US20210322574A1	Itzhak MENDEL Eyal BREITBART	Israel Israel	SHIN, DANA H
2018-06-08	16003173	Formulations and Dosage Forms of Oxidized Phospholipids	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20190008880A1	Naamit SHER Victor M. YOUNG Alyn MCNAUGHTON Massoud BAKHSHAEE Ian Robert WILDING	Israel United Kingdom United Kingdom United Kingdom United Kingdom	YU, HONG
2018-01-26	15747920	Motile Sperm Domain Containing Protein 2 and Cancer	VASCULAR BIOGENICS LTD.	Abandoned -- Failure to Respond to an Office Action	US20190040150A1	Itzhak Mendel Oshrat PROPHETA-MEIRAN Yaniv SALEM Anat SHOHAM Niva YACOV Eyal BREITBART	Israel Israel Israel Israel Israel Israel	MOSELEY II, NELSON B
2018-01-26	15747918	Motile Sperm Domain Containing Protein 2 and Inflammation	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20180214543A1	Itzhak Mendel Oshrat PROPHETA-MEIRAN Yaniv SALEM Anat SHOHAM Eyal BREITBART	Israel Israel Israel Israel Israel	KEMMERER, ELIZABETH
2017-07-06	15643430	METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS	Vascular Biogenics Ltd. MEMORIAL SLOANE-KETTERING CANCER CENTER	Abandoned -- Failure to Respond to an Office Action	US20180015183A1	Richard N. KOLESNICK Branka STANCEVIC Michel SADELAIN Zvi FUKS Nira VARDA-BLOOM Dror HARATS	United States United States United States United States Israel Israel	SINGH, ANOOP KUMAR
2016-07-12	15208335	METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS	Vascular Biogenics, Ltd. Memorial Sloan-Kettering Cancer Center	Expressly Abandoned -- During Examination	US20180015184A1	Richard N. Kolesnick Branka Stancevic Michel Sadelain Zvi Fuks Nira Varda-Bloom Dror Harats	United States United States United States United States Israel Israel	POPA, ILEANA
2016-02-08	15018158	Formulations and Dosage Forms of Oxidized Phospholipids	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20160220590A1	Naamit SHER Victor M. YOUNG Alyn MCNAUGHTON Massoud BAKHSHAEE Ian Robert WILDING	Israel United Kingdom United Kingdom United Kingdom United Kingdom	YU, HONG
2015-11-23	14949779	TREATMENT METHODS USING ADENOVIRUS	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20160143968A1	Eyal BREITBART Andrea Leubitz Erez Feige	Israel Israel Israel	SGAGIAS, MAGDALENE K
2015-02-13	14622093	Combined Treatment Utilizing VB-201	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20160008381A1	Yael COHEN Niva Yacov Eyal Breitbart	Israel Israel Israel	STRONG, TORI
2014-08-15	14379058	METHODS FOR TREATING PSORIASIS AND VASCULAR INFLAMMATION	VASCULAR BIOGENICS LTD.	Abandoned -- Incomplete Application (Pre-examination)	US20160038518A1	Naamit SHER Andrea LEUBITZ Eyal BREITBART	Israel Israel Israel
2014-06-12	14364705	TREATMENT OF INFLAMMATION	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20150320773A1	ITZHAK MENDEL Erez Feige Niva Yacov Oshrat Propheta-Meiran Eyal Breitbart Yaniv Salem	Israel Israel Israel Israel Israel Israel	LEE, ANDREW P
2013-10-21	14059426	PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS	VASCULAR BIOGENICS LTD.	Abandoned -- Failure to Respond to an Office Action	US20140155467A1	Dror HARATS Shoshana GREENBERGER Eyal BREITBART Livnat BANGIO Michael PELED	Israel Israel Israel Israel Israel	QIAN, CELINE X
2013-03-14	13828883	Oxidized Lipid Compounds and Uses Thereof	VASCULAR BIOGENICS LTD.	Abandoned -- Failure to Respond to an Office Action	US20130203707A1	Eti KOVALEVSKI-ISHAI Zeev Ziniuk Gideon Halperin Itzhak Mendel Erez Feige Niva Yacov Eyal Breitbart	Israel Israel Israel Israel Israel Israel Israel	YOO, SUN JAE
2013-03-14	13828643	Combined Treatment Utilizing VB-201	VASCULAR BIOGENICS LTD.	Abandoned -- Failure to Respond to an Office Action	US20130225525A1	Yael COHEN Niva YACOV Eyal BREITBART	Israel Israel Israel	STRONG, TORI
2013-03-14	13826396	Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20130295053A1	Livnat BANGIO Naamit Sher Eyal Breitbart	Israel Israel Israel	NOBLE, MARCIA STEPHENS
2013-03-12	13797160	Methods for Use of a Specific Anti-Angiogenic Adenoviral Agent	VASCULAR BIOGENICS LTD.	Abandoned -- Failure to Respond to an Office Action	US20130280217A1	YAEL COHEN NAAMIT SHER EREZ FEIGE LIVNAT BANGIO EYAL BREITBART	Israel Israel Israel Israel Israel	MARVICH, MARIA
2013-03-12	13796991	Methods for Use of a Specific Anti-Angiogenic Adenoviral Agent	Vascular Biogenics Ltd.	Abandoned -- Failure to Respond to an Office Action	US20130280216A1	Yael COHEN Naamit Sher Erez Feige Livnat Bangio Eyal Breitbart	Israel Israel Israel Israel Israel	MARVICH, MARIA